TYMLOS TDS Trademark
Trademark Overview
On Friday, July 30, 2021, a trademark application was filed for TYMLOS TDS with the United States Patent and Trademark Office. The USPTO has given the TYMLOS TDS trademark a serial number of 90857306. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2023. This trademark is owned by Radius Health, Inc.. The TYMLOS TDS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in the treatment of bone diseases; Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparat...
General Information
Serial Number | 90857306 |
Word Mark | TYMLOS TDS |
Filing Date | Friday, July 30, 2021 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, October 30, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 2, 2022 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for use in the treatment of bone diseases; Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma |
NOT AVAILABLE | "TDS" |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 27, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Radius Health, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 02110 |
Party Name | Radius Health, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 02110 |
Trademark Events
Event Date | Event Description |
Tuesday, August 3, 2021 | NEW APPLICATION ENTERED |
Monday, September 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, February 26, 2022 | ASSIGNED TO EXAMINER |
Saturday, February 26, 2022 | NON-FINAL ACTION E-MAILED |
Saturday, February 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, February 26, 2022 | NON-FINAL ACTION WRITTEN |
Thursday, June 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, June 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, June 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, June 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, July 13, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, August 2, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, August 2, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 27, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, March 22, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, March 22, 2023 | SOU EXTENSION 1 FILED |
Wednesday, March 22, 2023 | SOU EXTENSION 1 GRANTED |
Friday, March 24, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, October 30, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Monday, October 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |